ArticleCancer letters2022

PKC agonism restricts innate immune suppression, promotes antigen cross-presentation and synergizes with agonistic CD40 antibody therapy to activate CD8

Mehdi Chaib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.